Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
British Journal of Clinical Pharmacology|August 31, 2006
Population pharmacokinetics of darbepoetin alfa in healthy subjectsBalaji Agoram, Liviawati Sutjandra, John T SullivanJournal of Pharmacokinetics and Pharmacodynamics|July 1, 2015
Using early biomarker data to predict long-term bone mineral density: application of semi-mechanistic bone cycle model on denosumab dataJenny Zheng, Erno van Schaick, Liviawati Sutjandra Wu, et al.Cancer Chemotherapy and Pharmacology|September 28, 2010
Population pharmacokinetic/pharmacodynamic modeling for the time course of tumor shrinkage by motesanib in thyroid cancer patientsJian-Feng Lu, Laurent Claret, Liviawati Sutjandra, et al.Pharmaceutical Research|December 20, 2012
Pharmacokinetic and pharmacodynamic modeling of romiplostim in animalsWojciech Krzyzanski, Liviawati Sutjandra, Juan Jose Perez-Ruixo, et al.Journal of Clinical Pharmacology|September 3, 2009
Population pharmacokinetic analysis of panitumumab in patients with advanced solid tumorsPeiming Ma, Bing-Bing Yang, Yow-Ming Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2012
Denosumab dose selection for patients with bone metastases from solid tumorsSameer Doshi, Liviawati Sutjandra, Jenny Zheng, et al.Clinical Pharmacokinetics|November 18, 2011
Population pharmacokinetic meta-analysis of denosumab in healthy subjects and postmenopausal women with osteopenia or osteoporosisLiviawati Sutjandra, Rachelle D Rodriguez, Sameer Doshi, et al.Pharmaceutical Research|June 9, 2017
Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine SubjectsThuy Vu, Peiming Ma, Jiyun Sunny Chen, et al.Clinical Pharmacokinetics|March 17, 2012
Population pharmacokinetic analysis of denosumab in patients with bone metastases from solid tumoursLeonid Gibiansky, Liviawati Sutjandra, Sameer Doshi, et al.Pageof 1